Şensoy Özge
Department of Computer Engineering, The School of Engineering and Natural Sciences, İstanbul Medipol University, İstanbul Turkey.
Turk J Chem. 2020 Apr 1;44(2):409-420. doi: 10.3906/kim-1910-46. eCollection 2020.
β -arrestins are responsible for termination of G protein-coupled receptor (GPCR)-mediated signaling. Association of single nucleotide variants with onset of crucial diseases has made this protein family hot targets in the field of GPCR-mediated pharmacology. However, impact of these mutations on function of these variants has remained elusive. In this study, structural and dynamical properties of one of β -arrestin2 (arrestin 3) variants, A248T, which has been identified in some cancer tissue samples, were investigated via molecular dynamics simulations. The results showed that the variant underwent structural rearrangements which are seen in crystal structures of active arrestin. Specifically, the "short helix" unravels and the "gate loop" swings forward as seen in crystal structures of receptor-bound and GPCR phosphopeptide-bound arrestin. Moreover, the "finger loop" samples upward position in the variant. Importantly, these regions harbor crucial residues that are involved in receptor binding interfaces. Cumulatively, these local structural rearrangements help the variant adopt active-like domain angle without perturbing the "polar core". Considering that phosphorylation of the receptor is required for activation of arrestin, A248T might serve as a model system to understand phosphorylation-independent activation mechanism, thus enabling modulation of function of arrestin variants which are activated independent of receptor phosphorylation as seen in cancer.
β -抑制蛋白负责终止G蛋白偶联受体(GPCR)介导的信号传导。单核苷酸变异与关键疾病发病的关联使这个蛋白家族成为GPCR介导药理学领域的热门靶点。然而,这些突变对这些变异体功能的影响仍不清楚。在本研究中,通过分子动力学模拟研究了在一些癌症组织样本中鉴定出的β -抑制蛋白2(抑制蛋白3)的一个变异体A248T的结构和动力学特性。结果表明,该变异体发生了在活性抑制蛋白晶体结构中可见的结构重排。具体而言,如在与受体结合和与GPCR磷酸肽结合的抑制蛋白晶体结构中所见,“短螺旋”解开,“门环”向前摆动。此外,“指环”在变异体中处于向上的位置。重要的是,这些区域含有参与受体结合界面的关键残基。总的来说,这些局部结构重排有助于变异体采用类似活性的结构域角度,而不会干扰“极性核心”。考虑到抑制蛋白的激活需要受体的磷酸化,A248T可能作为一个模型系统来理解磷酸化非依赖性激活机制,从而能够调节如在癌症中所见的独立于受体磷酸化而被激活的抑制蛋白变异体的功能。